Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.000001 par value per share
-
Shares outstanding
-
6.57M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
92.1M
-
Shares change
-
-9.55M
-
Total reported value, excl. options
-
$60.9M
-
Value change
-
-$6.26M
-
Put/Call ratio
-
0.08
-
Number of buys
-
31
-
Number of sells
-
-33
-
Price
-
$0.66
Significant Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q1 2023
86 filings reported holding TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share as of Q1 2023.
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.1M shares
.
Largest 10 shareholders include Curative Ventures V LLC (38M shares), Vivo Capital, LLC (12.5M shares), CPMG Inc (8.22M shares), BAKER BROS. ADVISORS LP (5.27M shares), BlackRock Inc. (4.57M shares), CITIGROUP INC (4.03M shares), VANGUARD GROUP INC (2.99M shares), Western Standard LLC (1.8M shares), Samsara BioCapital, LLC (1.79M shares), and MARSHALL WACE, LLP (1.62M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.